Tspinal anesthesia addition of new drug magnesium to routine local anesthetics
Phase 4
Completed
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2019/07/020288
- Lead Sponsor
- Mahatma Gandhi Medical Collage and Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
ASA 1 and 2 patients,
Patients posted for all infraumblical surgeries of approximatly 2 hours duration,
Minimal expected bloods loss surgeries.
Exclusion Criteria
Patient unwilling to participate,
Pregnant and breast feeding mothers,
Patient with coagulation or bleeding disorders,
Local spinal site infection,
Spinal abnormalities or spinal instrumentation procedures,
BMI >30,
Patient posted for surgeries for more than 2 hours duration,
Patients with unstable hemodynamics.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total duration of sensory loss.Timepoint: 2 mins for first 10 mins,there after every 5 mins till fixation level is acheived.Every 15 mins till regression to T10 level thereafter every 30 mins till complete regression to S2 level.
- Secondary Outcome Measures
Name Time Method a)Total duration of motors blockade, <br/ ><br>b)Quality of post op analgesia, <br/ ><br>c)Hemodynamic parameters, <br/ ><br>Associated complications.Timepoint: a)Bromage scale from grade 0 to 3 <br/ ><br>b)At 3 hrs,6 hrs,9 hrs,18 hrs and 24 hrs. <br/ ><br>c)for 24 hours.